Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Ge

Scope

The scope of this report includes - - Data and analysis on the cancer supportive care products market. - Annualized market data for the cancer supportive care products market from 2001 to 2009, with forecasts to 2016. - Market data on the therapeutic landscape which covers oral mucositis and dry mouth, chemotherapy-induced nausea and vomiting, cancer pain, chemotherapy-induced anemia, chemotherapy-induced neutropenia and bone metastases, including market size, market share, annual cost of therapy, treatment usage patterns such as prevalence population and prescription population. - Key drivers and restraints that have had a significant impact on the market and on each indication. - The geographic landscape that covers the US, the top five countries of Europe (the UK, France, Germany, Spain and Italy) and Japan. - The competitive landscape of the cancer supportive care products market which includes companies such as Amgen, Johnson & Johnson, Roche, Novartis and Pfizer - Key M&A activities and Licensing Agreements that took place from 2008 to 2010 in the cancer supportive care products market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to - - Align your product portfolio to the markets with high growth potential. - Develop market-entry and market expansion strategies by identifying the leading countries and therapeutic segments poised for strong growth. - Devise a more tailored country strategy through the understanding of key drivers and barriers of each region’s pharmaceutical market. - Develop key strategic initiatives by understanding the key focus areas of leading companies. - Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Companies Mentioned

Amgen Johnson & Johnson F. Hoffmann-La Roche Novartis Pfizer

Table of Contents:

1 Table of Contents 1 Table of Contents 4 1.1 List of Tables 7 1.2 List of Figures 9 2 Cancer Supportive Care Products Market: Introduction 12 2.1 GBI Research Report Guidance 12 3 Cancer Supportive Care Products Market: Market Overview 13 3.1 Revenue 13 3.2 Average Annual Cost of Therapy 14 3.3 Therapeutic Segmentation 15 3.4 Geographic Segmentation 16 3.5 Generic Share in the Cancer Supportive Care Products Market 20 3.6 Drivers and Restraints of Cancer Supportive Care Products Market 21 3.6.1 Drivers 21 3.6.2 Restraints 22 3.7 Unmet Needs 23 3.7.1 Efficacy 23 3.7.2 Safety 23 3.7.3 Price 23 3.8 Major Drug Classes 24 3.8.1 Anti-infectives (Oral Mucositis) 24 3.8.2 Anti-emetics (CINV) 24 3.8.3 Bisphosphonates (Bone Metastases) 25 3.8.4 Erythropoietin Stimulating Agents (CIA) 25 3.8.5 Granulocyte Colony Stimulating Factors (CINP) 26 3.8.6 Opioid Analgesics (Cancer Pain and Bone Metastases) 26 3.8.7 NSAIDs (Cancer Pain and Bone Metastases) 26 3.8.8 Monoclonal Antibodies (Bone Metastases) 27 4 Cancer Supportive Care Products Market: Therapeutic Landscape 28 4.1 Oral Mucositis and Dry Mouth Market 28 4.1.1 Introduction 28 4.1.2 Revenue 29 4.1.3 Annual Cost of Therapy 30 4.1.4 Treatment Usage Patterns 31 4.1.5 Drivers for the Oral Mucositis and Dry Mouth Market 33 4.1.6 Restraints for the Oral Mucositis and Dry Mouth Market 34 4.1.7 Geographical Segmentation 34 4.2 Chemotherapy Induced Nausea and Vomiting Market 38 4.2.1 Introduction 38 4.2.2 Revenue 40 4.2.3 Annual Cost of Therapy 41 4.2.4 Treatment Usage Patterns 42 4.2.5 Drivers for the Chemotherapy Induced Nausea and Vomiting Market 44 4.2.6 Restraints for the Chemotherapy Induced Nausea and Vomiting Market 45 4.2.7 Geographical Landscape 46 4.3 Cancer Pain Market 49 4.3.1 Introduction 49 4.3.2 Revenue 49 4.3.3 Annual Cost of Therapy 50 4.3.4 Treatment Usage Patterns 51 4.3.5 Drivers for the Cancer Pain Market 56 4.3.6 Restraints for the Cancer Pain Market 56 4.3.7 Geographical Landscape 57 4.4 Chemotherapy Induced Anemia Market 60 4.4.1 Introduction 60 4.4.2 Revenue 60 4.4.3 Annual Cost of Therapy 62 4.4.4 Treatment Usage Patterns 63 4.4.5 Drivers for the Chemotherapy Induced Anemia Market 66 4.4.6 Restraints for the Chemotherapy Induced Anemia Market 66 4.4.7 Geographical Landscape 67 4.5 Chemotherapy Induced Neutropenia Market 70 4.5.1 Introduction 70 4.5.2 Revenue 71 4.5.3 Annual Cost of Therapy 72 4.5.4 Treatment Usage Patterns 73 4.5.5 Drivers for the Chemotherapy Induced Neutropenia Market 76 4.5.6 Restraints for the Chemotherapy Induced Neutropenia Market 76 4.5.7 Geographical Landscape 77 4.6 Bone Metastases Market 79 4.6.1 Introduction 79 4.6.2 Revenue 80 4.6.3 Annual Cost of Therapy 81 4.6.4 Treatment Usage Patterns 82 4.6.5 Drivers for the Bone Metastases Market 85 4.6.6 Restraints for the Bone Metastases Market 85 4.6.7 Geographical Landscape 86 5 Cancer Supportive Care Products Market: Geographical Landscape 89 5.1 The US 89 5.1.1 Revenue 89 5.1.2 Average Annual Cost of Therapy 90 5.1.3 Therapeutic Segmentation 91 5.2 Top Five Countries of Europe 92 5.2.1 Revenue 92 5.2.2 Average Annual Cost of Therapy 93 5.2.3 Therapeutic Segmentation 94 5.2.4 Geographic Segmentation 95 5.3 Japan 96 5.3.1 Revenue 96 5.3.2 Average Annual Cost of Therapy 97 5.3.3 Therapeutic Segmentation 98 6 Cancer Supportive Care Products Market: Pipeline Analysis 99 6.1 Introduction 99 6.1.1 Research and Development Pipeline – Oral Mucositis and Dry Mouth 101 6.1.2 Research and Development Pipeline – Chemotherapy Induced Nausea and Vomiting 102 6.1.3 Research and Development Pipeline – Cancer Pain 103 6.1.4 Research and Development Pipeline – Chemotherapy Induced Anemia 104 6.1.5 Research and Development Pipeline – Chemotherapy Induced Neutropenia 105 6.1.6 Research and Development Pipeline – Bone Metastases 106 6.2 Profiles of Promising Drugs in the Cancer Supportive Care Products Market 107 6.2.1 Xgeva/Prolia (denosumab) – Bone Metastases 107 6.2.2 Alpharadin – Bone Metastases 108 6.2.3 MAXY-G34 – Chemotherapy Induced Neutropenia 109 6.2.4 Lactermin – Oral Mucositis 109 6.2.5 Xen2174 – Cancer Pain 110 6.2.6 Tectin – Cancer Pain 111 6.2.7 NasalFent – Cancer Pain 112 7 Cancer Supportive Care Products Market: Competitive Landscape 113 7.1 Market Share Analysis 113 7.2 Competitive Profiling 114 7.2.1 Amgen 114 7.2.2 Johnson & Johnson 116 7.2.3 F. Hoffmann-La Roche 118 7.2.4 Novartis 120 7.2.5 Pfizer 122 8 Cancer Supportive Care Products Market: Deals Landscape 124 8.1 M&A and Licensing Agreements 124 8.1.1 Deals by Year 124 8.1.2 Deals by Deal Type 125 8.1.3 Deals by Indication 126 8.1.4 Deals by Value ($m) 127 8.1.5 Deals by Geography 128 8.1.6 Major Acquisitions in the Cancer Supportive Care Products Market 128 8.1.7 Major Licensing Agreements in the Cancer Supportive Care Products Market 129 9 Cancer Supportive Care Products Market: Appendix 131 9.1 Market Definitions 131 9.2 Abbreviations 131 9.3 Research Methodology 133 9.3.1 Coverage 133 9.3.2 Primary Research 134 9.3.3 Forecasts 134 9.3.4 Expert Panel Validation 136 9.4 Contact Us 137 9.5 Disclaimer 137 9.6 Sources 137

List of Tables

Table 1: Cancer Supportive Care Products Market, Global, Revenue ($m), 2001–2009 13 Table 2: Cancer Supportive Care Products Market, Global, Revenue Forecast ($m), 2009–2016 13 Table 3: Cancer Supportive Care Products Market, Global, Average Annual Cost of Therapy ($), 2001–2009 14 Table 4: Cancer Supportive Care Products Market, Global, Average Annual Cost of Therapy ($), 2009–2016 14 Table 5: Cancer Supportive Care Products Market, Geographical Segmentation, Revenue ($m), 2001–2009 16 Table 6: Cancer Supportive Care Products Market, Geographical Segmentation, Revenue ($m), 2009–2016 17 Table 7: Cancer Supportive Care Products Market, Sales of Generics Versus Branded Drugs ($m), 2001-2009 20 Table 8: Cancer Supportive Care Products Market, Sales of Generics Versus Branded Drugs ($m), 2009-2016 20 Table 9: Oral Mucositis and Dry Mouth, Global, Revenue ($m), 2001–2009 29 Table 10: Oral Mucositis and Dry Mouth, Global, Revenue Forecast ($m), 2009–2016 29 Table 11: Oral Mucositis and Dry Mouth, Global, Annual Cost of Therapy ($), 2001–2009 30 Table 12: Oral Mucositis and Dry Mouth, Global, Annual Cost of Therapy ($), 2009–2016 30 Table 13: Oral Mucositis and Dry Mouth, Global, Treatment Usage Pattern (‘000), 2001–2009 31 Table 14: Oral Mucositis and Dry Mouth, Global, Treatment Usage Pattern (‘000), 2009–2016 31 Table 15: Oral Mucositis and Dry Mouth, Geographical Segmentation, Revenue ($m), 2001–2009 35 Table 16: Oral Mucositis and Dry Mouth, Geographical Segmentation, Revenue ($m), 2009–2016 35 Table 17: Chemotherapy Induced Nausea and Vomiting, Emetic Risk Levels of Major Chemotherapeutic Agents 39 Table 18: Chemotherapy Induced Nausea and Vomiting, Global, Revenue ($m), 2001–2009 40 Table 19: Chemotherapy Induced Nausea and Vomiting, Global, Revenue Forecast ($m), 2009–2016 40 Table 20: Chemotherapy Induced Nausea and Vomiting, Global, Annual Cost of Therapy ($), 2001–2009 41 Table 21: Chemotherapy Induced Nausea and Vomiting, Global, Annual Cost of Therapy ($), 2009–2016 41 Table 22: Chemotherapy Induced Nausea and Vomiting, Global, Treatment Usage Pattern (‘000), 2001–2009 42 Table 23: Chemotherapy Induced Nausea and Vomiting, Global, Treatment Usage Pattern (‘000), 2009–2016 42 Table 24: Chemotherapy Induced Nausea and Vomiting, Geographical Segmentation, Revenue ($m), 2001–2009 46 Table 25: Chemotherapy Induced Nausea and Vomiting, Geographical Segmentation, Revenue ($m), 2009–2016 46 Table 26: Cancer Pain, Global, Revenue ($m), 2001–2009 49 Table 27: Cancer Pain, Global, Revenue Forecast ($m), 2009–2016 50 Table 28: Cancer Pain, Global, Annual Cost of Therapy ($), 2001-2009 50 Table 29: Cancer Pain, Global, Annual Cost of Therapy ($), 2009-2016 50 Table 30: Cancer Pain, Global, Treatment Usage Patterns (‘000), 2001-2009 51 Table 31: Cancer Pain, Global, Treatment Usage Patterns (‘000), 2009-2016 52 Table 32: Cancer Pain, Geographical Segmentation, Revenue ($m), 2001–2009 57

For more information kindly visit : http://www.bharatbook.com/detail.asp?id=185840&rt=Cancer-Supportive-Care-Products-Market-to-2016-Market-is-Expected-to-Decline-after-2014-Due-to-Generic-Erosion-and-Entry-of-Biosimilars.html

Related Reports

Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report http://www.bharatbook.com/detail.asp?id=126726&rt=Gastrointestinal-StomachCancer-Therapy-Area-Pipeline-Report.html Colorectal and Colon Cancer Therapy Area Pipeline Report http://www.bharatbook.com/detail.asp?id=126727&rt=Colorectal-and-Colon-Cancer-Therapy-Area-Pipeline-Report.html         -30- Or

Contact us at :

Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info@bharatbook.com Website: www.bharatbook.com Follow us on twitter: http://twitter.com/#!/BharatBook Please visit our blog at http://bharatresearch.wordpress.com

Related Articles - Demand Forecast, Market, Market Forecast, Market Growth, Market Leaders, Market Share, Market Size, Research, Cancer, Market Report, Report,

Email this Article to a Friend! Receive Articles like this one direct to your email box! Subscribe for free today!